Table 1.
Gene | IPF of Upper Lobe vs. Control |
IPF of Lower Lobe vs. Control |
|||
---|---|---|---|---|---|
logFC | Adjusted P Value | logFC | Adjusted P Value | ||
IFNγ | IFNG | 0.961604 | 1.02 × 10−26 | 0.755063 | 0.428627 |
IFNGR1 | −0.64487 | 1.13 × 10−141 | −0.37189 | 3.25 × 10−9 | |
IRF1 | — | — | −0.28732 | 5.24 × 10−7 | |
IRF4 | 0.268594 | 1.51 × 10−42 | — | — | |
IRF8 | 0.784697 | 2.13 × 10−138 | 0.301498 | 5.57 × 10−5 | |
Cytotoxicity | GNLY | 0.550427 | 9.85 × 10−58 | — | — |
GZMA | −0.32322 | 2.89 × 10−22 | — | — | |
GZMB | 1.426721 | 2.18 × 10−90 | −0.64957 | 0.011556 | |
GZMH | 0.280219 | 1.29 × 10−10 | — | — | |
GZMK | −0.35484 | 3.16 × 10−45 | 0.51977 | 9.09 × 10−38 | |
GZMM | — | — | −0.28041 | 5.24 × 10−12 | |
PRF1 | — | — | −0.27861 | 0.006536 | |
ER stress | DNAJA1 | — | — | 0.288644 | 2.02 × 10−12 |
DNAJB1 | −0.30486 | 1 | 0.93242 | 1.31 × 10−43 | |
DUSP5 | 0.552546 | 1.87 × 10−100 | — | — | |
HSP90AA1 | −0.27286 | 1 | 0.683977 | 2.80 × 10−32 | |
HSPA1A | −0.62515 | 7.68 × 10−47 | 1.253565 | 2.56 × 10−44 | |
HSPA1B | −0.35989 | 8.46 × 10−66 | 0.726816 | 1.02 × 10−21 | |
XBP1 | — | — | −0.35802 | 5.26 × 10−38 | |
HSPB1 | — | — | 0.372697 | 4.72 × 10−39 | |
HSPH1 | — | — | 0.261661 | 2.59 × 10−18 | |
HSP90AB1 | — | — | 0.317723 | 3.64 × 10−23 | |
MT zinc metabolism | MT1A | −0.26348 | 3.40 × 10−8 | −0.29711 | 4.34 × 10−14 |
MT1E | −0.3746 | 1.66 × 10−18 | −0.39028 | 7.47 × 10−13 | |
MT1M | −0.30203 | 2.02 × 10−15 | −0.32251 | 3.82 × 10−10 | |
MT1X | −0.67098 | 2.36 × 10−23 | −0.55898 | 0.04864 | |
MT2A | — | — | −0.646 | 3.66 × 10−5 |
Definition of abbreviations: ER = endoplasmic reticulum; FC = fold change; IPF = idiopathic pulmonary fibrosis; MT = metallothionein.
The FC was calculated with the expression by the patients with IPF versus that by control subjects, and a Wilcoxon rank sum test was used to determine the P value. Cells without data mean that the statistics were not significant.